11 results
6-K
CNTB
Connect Biopharma Holdings Ltd
30 Dec 22
Connect Biopharma Provides Business and Clinical Development Program Update
8:00am
that it had determined, in light of the current macroeconomic climate and challenging funding environment, to commence its Global Phase 3 program
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
30 Dec 22
Connect Biopharma Provides Business and Clinical Development Program Update
8:00am
and asthma,” said Zheng Wei, PhD, Co-Founder and CEO of Connect Biopharma. “Yet, in light of the current macroeconomic climate and challenging funding
20-F
2021 FY
CNTB
Connect Biopharma Holdings Ltd
31 Mar 22
Annual report (foreign)
4:33pm
and potentially adverse tax consequences;
changes in a specific country’s or region’s political and cultural climate or economic condition
424B4
xeh4r2a
19 Mar 21
Prospectus supplement with pricing info
4:49pm
F-1/A
1apsnsf
18 Mar 21
Registration statement (foreign) (amended)
6:15am
F-1/A
r4p0 06ps5thbqf
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1
3n5pze47
26 Feb 21
Registration statement (foreign)
4:56pm
DRS/A
e5i9svk07bh5lang6w33
26 Jan 21
Draft registration statement (amended)
12:00am
DRS
ecwzico 2dq8w
17 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next